In case you haven't had enough artificial intelligence, the US Food and Drug Administration is now outsourcing its oversight duties to a large language model (LLM.) In an article published in the Journal of the American Medical Association (JAMA), FDA bureaucrats Marty Makary and Vinay Prasad (the latter of whom is a noted critic of COVID mask mandates and vaccine boosters) laid out a five-point list of priorities that the federal agency is hoping to tackle. Among them is "unleashing AI," a plan
The article from Yahoo News discusses how the FDA has been outsourcing the inspection of drugs, food, and medical devices to private companies, a practice that has raised concerns about conflicts of interest and the effectiveness of these inspections. Since 2011, the FDA has increasingly relied on these third-party auditors, particularly for products manufactured overseas, due to budget constraints and the need to expand its oversight. Critics argue that this delegation could compromise public safety, as these private firms may not be as thorough or impartial as the FDA. The article highlights specific instances where these third-party inspections failed to identify serious issues that were later discovered by the FDA, prompting calls for more transparency and stricter oversight of the outsourcing process.